AI in science

Colossal Biosciences, the US biotech company working to bring back extinct species such as the woolly mammoth, has announced a new AI platform to accelerate its de-extinction research. Entrepreneur Peter Diamandis has simultaneously launched a fund to back startups building on the platform, linking the effort to a wider wave of investment in applied AI for biotechnology.

Sufiyan A appeared on TRS, The Ranveer Show, for a conversation titled 'Proof of God - Quantum Science Explained', covering quantum science, time travel, artificial intelligence and the nature of reality. The episode argues that modern physics can be read as evidence for a higher power, and the discussion has drawn hundreds of thousands of likes from listeners.

German science channel Kurzgesagt (Dinge Erklärt) has released a piece asking what happens now that artificial intelligence has done 'the unthinkable.' The item frames AI's latest advances as a turning point, exploring the consequences for society and what steps might follow. It is drawing large attention among German-speaking audiences amid ongoing global debate about rapid AI progress.

A new science discussion argues that mathematicians may be the first professionals to feel the impact of advanced AI. The claim is that because AI systems are increasingly capable of solving formal proofs and abstract problems, mathematics serves as an early warning sign for how automation could reshape skilled intellectual work more broadly.

OpenAI has announced it is running thousands of AI agents to comb through biological data and surface new research leads. The approach aims to accelerate scientific discovery by letting large numbers of agents analyse datasets in parallel and flag promising findings for researchers. The announcement is drawing wide attention in the science and technology communities, with discussion centring on what the agents actually found and how the method could be applied to other fields.

A former OpenAI science head has launched a new startup backed by $215 million in funding, according to Bloomberg. The move adds to a wave of high-profile departures from leading AI labs, where departing executives are raising large sums to build competing ventures. Details on the company's focus and investors beyond the funding amount have not been disclosed in the report.

A discussion is drawing wide attention to the question of whether biology could soon be 'solved' — whether advances in technology and data might eventually explain living systems completely. Viewers are debating how far science is from that point, with strong engagement suggesting the idea of cracking biology's fundamentals has struck a chord.

Hackaday, the engineering and maker blog, has published its daily links roundup for October 11, 2026, collecting short items on topics spanning making, science, and artificial intelligence. The regular feature gathers notable projects, articles, and news from around the web for hardware and electronics enthusiasts, and remains a staple of the site's coverage for the maker community.

Artificial intelligence is increasingly being positioned as a tool that could accelerate biological research, from analysing large datasets to suggesting new experimental directions. Scientists and commentators argue that AI systems may help researchers uncover patterns in biology that traditional methods have missed, potentially speeding up discoveries in medicine and the life sciences, though questions remain about validation and reliability.

An independent author is promoting a catalogue of audiobooks spanning mystery, romance, science fiction and fantasy, and thrillers, inviting listeners to discover new authors and narrators. The promotion stresses that the titles are 'absolutely no AI, guaranteed', positioning the work as human-narrated and human-written amid ongoing debate about AI-generated books.

A former OpenAI science lead has launched Warp Science, a new venture aiming to automate wet laboratory work using robots. The startup seeks to speed up experiments in biology and chemistry by replacing manual lab processes with robotic systems, following a broader industry push to apply artificial intelligence expertise to scientific research and laboratory automation.

Clarivate announced that it is seeing global demand for its AI-native Web of Science research intelligence tools. The company, which tracks scholarly citations and research analytics, is positioning artificial intelligence as central to the future of research discovery and evaluation. The announcement is being circulated via PR Newswire and is drawing attention within the science and research policy community.

OpenAI has acquired a tool designed to accelerate drug development workflows, a field where research and testing are notoriously slow. The move signals OpenAI's push to apply its artificial intelligence beyond chatbots and into pharmaceutical research, where AI could shorten discovery timelines and reduce costs. Industry watchers see it as part of a broader race among AI companies to expand into science and healthcare applications.

Cholesterol is drawing widespread attention across health and science news. A cardiologist writing in The Telegraph is urging people in midlife to learn their key cholesterol numbers, while Merck has reached a pipeline milestone on a cholesterol-lowering drug, boosting investor interest. Separately, OpenAI announced a mouse brain reasoning atlas built by GPT-Rosalind agents, adding to buzz around biology and brain research. Commenters are sharing advice on heart health and tracking the pharma news.

A new article examines how much of Star Trek's fictional technology has become reality. Smartphones, artificial intelligence and real-time translation already resemble the show's gadgets, but warp drives, transporters and true replicators remain out of reach, blocked by fundamental limits of physics. The piece weighs which futuristic technologies might one day be achieved and which will likely stay science fiction.

A new study published in an APS journal applies an extended technology acceptance model to high school students' willingness to use generative AI for physics learning. The research highlights disciplinary beliefs as a distal antecedent, suggesting that students' prior views of physics shape their attitudes toward adopting AI tools in the classroom.

Climate experts are examining how artificial intelligence is being applied across climate science, from improving weather and climate models to processing vast datasets and sharpening projections of future warming. The discussion covers the opportunities AI offers researchers as well as the limitations and risks of relying on machine learning tools for such a high-stakes field.

Demis Hassabis, the Google DeepMind chief and Nobel laureate, is drawing attention for comments suggesting artificial intelligence is on the verge of transforming the world in radical ways. An interview with the AI leader, published by Livemint, has fuelled fresh discussion in India and beyond about how soon advanced AI will reshape work, science and daily life.

A new opinion piece argues that decisions about how artificial intelligence is used in education should be grounded in the science of learning, rather than driven by hype or institutional pressure. The author suggests research on how people actually learn should shape when and how AI tools are adopted in classrooms. The argument is likely to spark debate among educators and policymakers weighing rapid AI adoption against evidence-based teaching.

Therna Biosciences has presented RNA-Logix, an AI-driven 'RNA biologist' platform designed to accelerate biological discovery and support the design of genomic medicines. The announcement was carried by Business Wire and picked up by life sciences news outlets. The company positions the technology as a way to automate RNA-focused research workflows for drug development, though no clinical or partnership details accompanied the reveal.

Private-market investors are increasingly looking at bioconvergence, the merging of biology with technologies such as AI, engineering and materials science, as a distinct investment theme. The discussion centres on how convergence across biotech, computing and devices is creating new categories of companies and reshaping where venture and growth capital is being deployed.

An artificial intelligence company known for building large language models has established its own biology laboratory and is running tests there. The lab is being used to explore how AI models can assist with scientific research, particularly in life sciences. The exact experiments under way have not been fully detailed, but the move signals growing investment by AI firms in hands-on scientific experimentation.

A feature lists five classic films that anticipated today's developments in artificial intelligence, drawing parallels between their fictional scenarios and current debates about AI. As artificial intelligence moves further into everyday life, audiences are revisiting older science fiction to see how accurately these movies predicted concerns about automation, machine intelligence and their impact on society.

FrontierCS 2, a benchmark that tests AI agents on genuine computer science research improvements rather than synthetic tasks, is drawing attention in the AI community. Observers say it measures whether models can contribute to real research work, a step beyond coding benchmarks, and debate what strong results would mean for AI's role in scientific progress.

Anthropic has appointed a former Harvard science dean to its oversight body, according to a Reuters report. The move places a senior figure from academic science leadership on the board that guides the AI company's governance, and signals Anthropic's continued effort to draw on expertise from research institutions as it manages scrutiny over how its systems are developed and deployed.

A Washington Post opinion piece argues that rapid advances in artificial intelligence, including AI's ability to assist in designing biological agents, require the United States to launch a large-scale, Manhattan Project-style national effort on biodefense. The column calls for mobilising government, science and industry to develop defenses against AI-enabled biological threats before such capabilities outpace existing safeguards.

A Communications of the ACM article argues that agency should serve as a new organizing abstraction for computer science. As computing systems increasingly act autonomously, the piece suggests that designing around the capacity of systems to act, rather than around data or computation alone, could reshape how the field frames its core concepts and education.

Clarivate has announced how artificial intelligence is being integrated into Web of Science to change the way researchers discover academic literature. The update focuses on using AI to help scholars find relevant studies, navigate citations, and surface research more efficiently within the database. The announcement is drawing attention among academics and research professionals tracking how AI tools reshape scientific search and scholarly publishing.